A Jansz

3.0k total citations
34 papers, 1.2k citations indexed

About

A Jansz is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, A Jansz has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 11 papers in Infectious Diseases and 7 papers in Clinical Biochemistry. Recurrent topics in A Jansz's work include Bacterial Identification and Susceptibility Testing (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). A Jansz is often cited by papers focused on Bacterial Identification and Susceptibility Testing (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). A Jansz collaborates with scholars based in Netherlands, United States and Canada. A Jansz's co-authors include W. A. De Boer, W. M. M. Driessen, G. N. J. Tytgat, Anne J. M. Loonen, Adriaan J. C. van den Brule, Petra Wolffs, Alje P. van Dam, Ed J. Kuijper, H. O. Nieweg and J. H. Oudbier and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

A Jansz

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Jansz Netherlands 18 394 394 282 250 160 34 1.2k
Alice S. Weissfeld United States 16 304 0.8× 678 1.7× 489 1.7× 247 1.0× 50 0.3× 60 1.6k
Arthur J. Morris New Zealand 17 392 1.0× 1.1k 2.9× 356 1.3× 125 0.5× 191 1.2× 30 1.6k
J Wüst Switzerland 21 527 1.3× 459 1.2× 480 1.7× 194 0.8× 59 0.4× 75 1.4k
Jung Oak Kang South Korea 20 217 0.6× 396 1.0× 608 2.2× 41 0.2× 66 0.4× 55 1.1k
Haragopal Thadepalli United States 19 495 1.3× 425 1.1× 407 1.4× 252 1.0× 159 1.0× 72 1.6k
Jean‐Louis Fauchere France 17 580 1.5× 192 0.5× 206 0.7× 21 0.1× 134 0.8× 57 1.1k
Eui Chong Kim South Korea 19 128 0.3× 472 1.2× 449 1.6× 174 0.7× 72 0.5× 73 1.1k
Mercedes Marı́n Spain 22 179 0.5× 495 1.3× 683 2.4× 218 0.9× 84 0.5× 47 1.0k
Veli‐Jukka Anttila Finland 25 295 0.7× 1.0k 2.6× 1.2k 4.3× 62 0.2× 72 0.5× 88 2.1k
Øyvind Kommedal Norway 19 101 0.3× 463 1.2× 365 1.3× 141 0.6× 74 0.5× 48 1.0k

Countries citing papers authored by A Jansz

Since Specialization
Citations

This map shows the geographic impact of A Jansz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Jansz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Jansz more than expected).

Fields of papers citing papers by A Jansz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Jansz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Jansz. The network helps show where A Jansz may publish in the future.

Co-authorship network of co-authors of A Jansz

This figure shows the co-authorship network connecting the top 25 collaborators of A Jansz. A scholar is included among the top collaborators of A Jansz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Jansz. A Jansz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friesema, Ingrid, Agnetha Hofhuis, A Jansz, et al.. (2023). Risk factors for acute toxoplasmosis in the Netherlands. Epidemiology and Infection. 151. e95–e95. 14 indexed citations
2.
Hees, C.L.M. van, Hannelore I. Bax, Tom Sprong, et al.. (2022). Treatment and Outcome of Culture-Confirmed Mycobacterium marinum Disease. Open Forum Infectious Diseases. 9(4). ofac077–ofac077. 12 indexed citations
3.
Faron, Matthew L., et al.. (2016). Automatic Digital Analysis of Chromogenic Media for Vancomycin-Resistant-Enterococcus Screens Using Copan WASPLab. Journal of Clinical Microbiology. 54(10). 2464–2469. 38 indexed citations
4.
Faron, Matthew L., Blake W. Buchan, Chiara Vismara, et al.. (2015). Automated Scoring of Chromogenic Media for Detection of Methicillin-Resistant Staphylococcus aureus by Use of WASPLab Image Analysis Software. Journal of Clinical Microbiology. 54(3). 620–624. 45 indexed citations
5.
Jansz, A, et al.. (2015). Urine flow cytometry can rule out urinary tract infection, but cannot identify bacterial morphologies correctly. Clinica Chimica Acta. 448. 86–90. 20 indexed citations
6.
Loonen, Anne J. M., et al.. (2012). Comparative Study Using Phenotypic, Genotypic, and Proteomics Methods for Identification of Coagulase-Negative Staphylococci. Journal of Clinical Microbiology. 50(4). 1437–1439. 42 indexed citations
7.
Smet, Anne Marie G. A. de, Jan Kluytmans, Hetty E. M. Blok, et al.. (2011). Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. The Lancet Infectious Diseases. 11(5). 372–380. 112 indexed citations
8.
Loonen, Anne J. M., et al.. (2011). An evaluation of three processing methods and the effect of reduced culture times for faster direct identification of pathogens from BacT/ALERT blood cultures by MALDI-TOF MS. European Journal of Clinical Microbiology & Infectious Diseases. 31(7). 1575–1583. 99 indexed citations
9.
Dam, Alje P. van & A Jansz. (2010). Capnocytophaga canimorsus infections in The Netherlands: a nationwide survey. Clinical Microbiology and Infection. 17(2). 312–315. 46 indexed citations
10.
Loonen, Anne J. M., A Jansz, Herman G. Kreeftenberg, et al.. (2010). Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods. European Journal of Clinical Microbiology & Infectious Diseases. 30(3). 337–342. 13 indexed citations
11.
Oostdijk, Evelien, Anne Marie G. A. de Smet, Hetty E. M. Blok, et al.. (2009). Ecological Effects of Selective Decontamination on Resistant Gram-negative Bacterial Colonization. American Journal of Respiratory and Critical Care Medicine. 181(5). 452–457. 121 indexed citations
12.
Belkum, Alex van, Bart C. Jacobs, Rogier Louwen, et al.. (2008). Can Campylobacter coli induce Guillain-Barré syndrome?. European Journal of Clinical Microbiology & Infectious Diseases. 28(5). 557–560. 13 indexed citations
13.
Mouton, Johan W. & A Jansz. (2001). The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands. Clinical Microbiology and Infection. 7(9). 486–491. 19 indexed citations
14.
Bogaert, Debby, et al.. (2001). Emergence of Rifampin‐ResistantStreptococcus pneumoniaeas a Result of Antimicrobial Therapy for Penicillin‐Resistant Strains. Clinical Infectious Diseases. 33(8). e93–e96. 8 indexed citations
15.
Griethuysen, A. J. van, A Jansz, & A. G. M. Buiting. (1996). Comparison of fluorescent BACTEC 9000 MB system, Septi-Chek AFB system, and Lowenstein-Jensen medium for detection of mycobacteria. Journal of Clinical Microbiology. 34(10). 2391–2394. 31 indexed citations
16.
Boer, W. A. De, et al.. (1995). Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. European Journal of Gastroenterology & Hepatology. 12(7). 1189–1194. 47 indexed citations
17.
Boer, W. A. De, W. M. M. Driessen, A Jansz, & G. N. J. Tytgat. (1995). Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. The Lancet. 345(8953). 817–820. 191 indexed citations
18.
Kuijper, Ed J., et al.. (1986). [A family with meningococcal infections].. PubMed. 130(49). 2213–6. 1 indexed citations
19.
Jansz, A & John H. Huber. (1967). FATAL GRANULOMATOUS DISEASE OF CHILDHOOD. The Lancet. 289(7494). 844–845. 13 indexed citations
20.
Nieweg, H. O., et al.. (1963). Haematological Side-effects of some Anti-Rheumatic Drugs. Annals of the Rheumatic Diseases. 22(6). 440–443. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice S. Weissfeld Breakdown of academic impact, for papers by Arthur J. Morris Breakdown of academic impact, for papers by J Wüst Breakdown of academic impact, for papers by Jung Oak Kang Breakdown of academic impact, for papers by Haragopal Thadepalli Breakdown of academic impact, for papers by Jean‐Louis Fauchere Breakdown of academic impact, for papers by Eui Chong Kim Breakdown of academic impact, for papers by Mercedes Marı́n Breakdown of academic impact, for papers by Veli‐Jukka Anttila Breakdown of academic impact, for papers by Øyvind Kommedal
Rankless by CCL
2026